Medical dictionary

Medical terminology normalized via MeSH, ICD-11, SNOMED CT.

62,341 terms indexed

• C5879145-((1-(2,6-dichlorobenzyl)piperidin-4-yl)methoxy)quinazoline-2,4-diamineMeSH

  inhibits DcpS protein

• C5870615-((1-(2-bromobenzoyl)-5-chloro-1H-indol-3-yl)methylene)-2-thioxodihydropyrimidine-4,6(1H,5H)-dioneMeSH

  inhibits DNA polymerase eta; structure in first source

• C5724875-((2'E)-3',7'-dimethyl-2',6'-octadienyl)-4-hydroxy-6-methoxy-1-isoindolinoneMeSH

  from the mushroom Hericium erinaceum; structure in first source

• C5820645-((2,4-diphenyl-3H-pyrido(3,4-b)(1,4)diazepin-3-yl)sulfonyl)quinolin-8-olMeSH

  an antischistsosomal agent that inhibits thioredoxin glutathione reductase; structure in first source

• C5834355-((2-(4-hydroxyphenyl)ethoxy)methyl)-1H-pyrrole-2-carbaldehydeMeSH

  isolated from Annulohypoxylon ilanense; structure in first source

• C5808095-((3,4-methylenedioxyphenylethane)methylamino)-1-p-hydroxyphenyl-1-penten-3-oneMeSH
• C5709225-((3,5-dichlorophenoxy)methyl)-1H-pyrazol-3(2H)-oneMeSH

  inhibits superoxide dismutase 1; structure in first source

• C5880285-((3-fluorophenyl)ethynyl)-N-(3-hydroxy-3-methylbutan-2-yl)picolinamideMeSH

  an mGlu5 agonist; structure in first source

• C5868405-((3-fluorophenyl)ethynyl)-N-(3-methyloxetan-3-yl)picolinamideMeSH

  an mGlu5 modulator; structure in first source

• C5709035-((4-(2-methoxyphenyl)piperazin-1-yl)methyl)-2,2-diphenylcyclopentan-1-olMeSH

  structure in first source

• C5606235-((4-(4-(2-ethoxy-5-(trifluoromethyl)-2,3-dihydro-1H-inden-1-yl)-3-methylpiperazin-1-yl)-4-methylpiperidin-1-yl)carbonyl)-4,6-dimethylpyrimidineMeSH

  structure in first source

• C5867215-((4-(5-(7,7-dimethyl-1,6-dioxaspiro(2.5)octan-5-yl)-3-methylpenta-2,4-dien-1-yl)cyclohexyl)amino)-5-oxopent-3-en-2-yl methylcarbamateMeSH

  structure in first source

• C5780675-((5-(4-bromo-3-chlorophenyl)furan-2-yl)methylene)-2-thioxothiazolidin-4-oneMeSH

  an anti-tubulin and antineoplastic agent; structure in first source

• C5830845-((5-bromo-1H-indol-3-yl)methylene)-3-(4-chlorobenzyl)thiazolidine-2,4-dioneMeSH

  structure in first source

• C5842505-((5-methylpyridin-3-yl)methyl)-2-phenylpyridineMeSH

  structure in first source

• C5807715-((6-phenyl-(1,2,4)triazolo(4,3-b)pyridazin-3-yl)methyl)isoquinolin-1(2H)-oneMeSH

  a c-Met receptor tyrosine kinase inhibitor; structure in first source

• C5696475-((N-benzyl-1H-indol-3-yl)methylene)pyrimidine-2,4,6(1H,3H,5H)trioneMeSH

  a radiosensitizing agent; structure in first source

• C5707345-((R)-1-hydroxyethyl)-furo(2,3-c)pyridineMeSH

  structure in first source

• C5862285-((alpha-D-galactopyranosyloxy)methyl)-1H-pyrrole-2-carbaldehydeMeSH

  from the kernel of Prinsepia uniflora; structure in first source

• C5687215-((pyrimidin-2-ylthio)methyl)-1,3,4-oxadiazole-2(3H)-thioneMeSH

  structure in first source

• C5856525-(1-(3-fluorophenyl)-1H-pyrazol-4-yl)-2H-tetrazoleMeSH

  structure in first source

• C5691175-(1-phenyl-1,2,3-triazol-4-yl)-2'-deoxycytidineMeSH

  structure in first source

• C5691185-(1-phenyl-1,2,3-triazol-4-yl)-2'-deoxyuridineMeSH

  structure in first source

• C5749585-(125I)iodo-sunitinibMeSH

  structure in first source

• C5762025-(13'Z-nonadecenyl)resorcinolMeSH

  from Mangifera indica gum; structure in first source

• C5623575-(1H-benzoimidazol-2-ylmethylsulfanyl)-2-methyl(1,2,4)triazolo(1,5-c)quinazolineMeSH

  a phosphodiesterase 10A (PDE10A) inhibitor; structure in first source

• C5716605-(1H-indol-3-yl-methylene)-2-thioxo-imidazolidin-4-oneMeSH

  has anti-inflammatory and antinociceptive activities

• C5736265-(1H-pyrrol-1-yl)-1,10-phenanthrolineMeSH

  has antineoplastic activity; structure in first source

• C5815745-(1H-pyrrolo(2,3-b)pyridin-3-ylmethyl)-N-((4-(trifluoromethyl)phenyl)methyl)pyridin-2-amineMeSH

  a dual FMS and KIT kinase inhibitor; structure in first source

• C5609525-(1H-tetrazol-1-yl)-1,2,4-triazoleMeSH

  structure in first source

• C5823705-(2,3-dichloro-4-(2-methylene-1-oxobutyl)phenoxymethyl)-3-methyl-1,2,4-oxadiazoleMeSH

  structure in first source

• C5809335-(2,3-dihydroxy-3-methylbutyloxy)-6,7-methylenedioxycoumarinMeSH

  has antineoplastic activity; structure in first source

• C5705415-(2,4-dihydroxy-5-isopropylphenyl)-4-(5-(morpholinomethyl)isoxazole-3-carbonylamino)isoxazole-3-carboxylic acid ethylamideMeSH

  structure in first source

• C5713875-(2,4-dimethylbenzyl)pyrrolidin-2-oneMeSH

  structure in first source

• C5734395-(2,5-phenylene-bis(oxy)diacetamide)-10,15,20-tris(triphenylamino)porphyrinato zinc(II)MeSH

  structure in first source

• C5769525-(2-((6-(2,2-difluoro-2-phenylethoxy)hexyl)amino)-1-hydroxyethyl)-8-hydroxyquinolin-2(1H)-oneMeSH

  structure in first source

• C5830925-(2-(1-(1-(3-ethyl-3-hydroxypentyloxy)ethyl)-7-methyldihydro-1H-inden-4(2H,5H,6H,7H,7alphaH)-ylidene)ethylidene)-2-methylenecyclohexane-1,3-diolMeSH

  a vitamin D receptor modulator; structure in first source

• C5707815-(2-(1-(1-(3-hydroxy-2,3-dimethylbutoxy)ethyl)-7alpha-methyldihydro-1H-inden-4(2H,5H,6H,7H,7alphaH)-ylidene)ethylidene)-2-methylenecyclohexane-1,3-diolMeSH

  a vitamin D receptor modulator and cardioprotective agent; structure in first source

• C5851565-(2-(1H-imidazol-1-yl)ethylthio)-3-(benzyloxy)-N-(4-isopropylthiazol-2-yl)pyridin-2-amineMeSH

  a glucokinase activator; structure in first source

• C5875885-(2-(2,4,6-trimethylphenyl)diazen-1-yl)quinolin-8-olateMeSH

  structure in first source

• C5698135-(2-(2-(2-cyanopyrrolidin-1-yl)-2-oxoethylamino)propyl)-5-(1H-tetrazol-5-yl)-10,11-dihydro-5H-dibenzo(a,d)cycloheptene-2,8-dicarboxylic acid bisdimethylamideMeSH

  structure in first source

• C5722575-(2-(4-chlorophenyl)hydrazono)-6-ethoxy-6-oxohexanoic acidMeSH

  structure in first source

• C5769115-(2-amino-(1,2,4)triazolo(1,5-a)pyridin-7-yl)-N-(tert-butyl)pyridine-3-sulfonamideMeSH

  structure in first source

• C5762845-(2-amino-2-carboxyethyl)-1H-imidazol-3-ium 7-hydroxy-2-oxo-6-(6-oxo-6,9-dihydro-1H-purin-9-yl)-4a,6,7,7a-tetrahydro-4H-1,3,5,2lamda(5)-furo(3,2-d)(1,3,2lamda(5))dioxaphosphinin-2-olateMeSH

  structure in first source

• C5737745-(2-amino-pyrimidin-4-yl)-1H-pyrroleMeSH

  structure in first source

• C5830095-(2-aminopropyl)indoleMeSH

  structure in first source

• C5724965-(2-ethoxy-5-(N-isopropyloxycarbonyl-aminosulfonyl))-1-methyl-3-propyl-1H-pyrazolo(4,3-d)pyrimidin-7(6H)-oneMeSH

  inhibits phosphodiesterase C of Trypanosoma cruzi; structure in first source

• C5874435-(2-hydroxybenzylidene)-2-((4-phenoxyphenyl)imino)thiazolidin-4-oneMeSH

  a microtubule depolymerizing agent; structure in first source

• C5745555-(2-hydroxybenzylidene)rhodanineMeSH

  structure in first source

• C5834345-(2-hydroxyethyl)-2-methyl-2-tetradecylfuran-3(2H)-oneMeSH

  isolated from Annulohypoxylon ilanense; structure in first source